{"slideshow_credits": null, "snippet": "Production of cheap copycat drugs for H.I.V. and cancer used by people in developing countries in Africa and Asia was ensured on Monday in a ruling by India\u2019s Supreme Court.", "abstract": "Indian Supreme Court rules that Indian makers of low-cost generic drugs can continue making copycat versions for diseases like HIV and cancer; debate over global drug pricing is highly contentious issue between developed countries and developing world, and ruling challenges pharmaceutical industry at a time when it is increasingly looking to emerging markets to counter lackluster sales in United States and Europe.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Gardiner", "role": "reported", "lastname": "HARRIS", "rank": 1, "organization": ""}, {"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 2, "organization": ""}], "original": "By GARDINER HARRIS and KATIE THOMAS", "contributor": "Gardiner Harris reported from New Delhi, and Katie Thomas from New York."}, "web_url": "http://www.nytimes.com/2013/04/02/business/global/top-court-in-india-rejects-novartis-drug-patent.html", "lead_paragraph": "Production of cheap copycat drugs for H.I.V. and cancer used by people in developing countries in Africa and Asia was ensured on Monday in a ruling by India\u2019s Supreme Court.", "headline": {"seo": "Top Court in India Rejects Novartis Drug Patent", "main": "Low-Cost Drugs in Poor Nations Get a Lift in Indian Court", "print_headline": "Low-Cost Drugs In Poor Nations Get Lift in Court"}, "_id": "515d85e3cf28d0219d000005", "word_count": "1287", "multimedia": [{"height": 126, "url": "images/2013/04/02/business/Patent/Patent-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/04/02/business/Patent/Patent-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 388, "url": "images/2013/04/02/business/Patent/Patent-articleLarge.jpg", "legacy": {"xlarge": "images/2013/04/02/business/Patent/Patent-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "388"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/04/02/business/Patent/Patent-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/04/02/business/Patent/Patent-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-04-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "India", "name": "glocations", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Novartis AG", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Inventions and Patents", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "Supreme Court of India", "name": "organizations", "is_major": "N", "rank": "6"}, {"value": "Decisions and Verdicts", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Third World and Developing Countries", "name": "subject", "is_major": "Y", "rank": "8"}], "blog": [], "subsection_name": "Global Business", "type_of_material": "News"}